A detailed history of Los Angeles Capital Management LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 218,110 shares of CDXC stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
218,110
Previous 44,875 386.04%
Holding current value
$1.34 Million
Previous $275,000 386.91%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
N/A
173,235 Added 386.04%
218,110 $1.34 Million
Q2 2025

Aug 06, 2025

SELL
$5.42 - $7.08 $422,461 - $551,850
-77,945 Reduced 63.46%
44,875 $275,000
Q1 2025

May 05, 2025

SELL
$5.26 - $8.55 $503,424 - $818,303
-95,708 Reduced 43.8%
122,820 $847,000
Q4 2024

Feb 04, 2025

BUY
$3.25 - $7.72 $710,216 - $1.69 Million
218,528 New
218,528 $1.16 Million
Q2 2021

Aug 05, 2021

BUY
$6.66 - $10.92 $203,096 - $333,005
30,495 New
30,495 $301,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $420M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.